selarsdi
(ustekinumab-aekn)Teva Pharmaceuticals USA, Inc.
Usage: SELARSDI™ is indicated for treating moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis in the same age group, and moderately to severely active Crohn’s disease and ulcerative colitis in adults.